Journal of Cutaneous Medicine and Surgery · 2014 · 16 citations · 6 references
MedicineDermatologyPathologyAutoimmunityDermatopathologyDiagnostic PathologyAutoantibodiesAutoimmune Disease DiagnosticsAutoimmune Skin DiseasesBiopsy InterpretationDiagnostic ImmunologyImmunopathology Of SkinAutoimmune Skin PathologyBullous DermatosesImmunofluorescence AssaysImmunofluorescence DiagnosisImmunofluorescence FindingsImmunofluorescence StainingPemphigoid DiseasesSkin Biopsy Diagnostics
BACKGROUND: Bullous pemphigoid (BP) is an autoimmune polymorphic skin disease characterized by erythematous papules and plaques and tense bullae. A skin biopsy for direct immunofluorescence (DIF) is used to detect autoantibodies and complement proteins. OBJECTIVE: We sought to determine which location would provide the highest probability of obtaining a positive DIF result. METHOD: We undertook a retrospective chart review of 1,423 DIF biopsies. Biopsies with a clinical suspicion of BP were designated as either lesional, perilesional, or indeterminate. RESULTS: Fifty percent of lesional DIF biopsies were positive, whereas 22% of perilesional and 12% of indeterminate biopsies had a positive DIF result. The odds ratio of a positive DIF from a lesional versus perilesional biopsy site was found to be 3.45 (95% CI 1.44-8.29). CONCLUSION: Clinicians are more likely to obtain a positive DIF result from a lesional nonbullous skin biopsy than from a perilesional or normal skin biopsy.
6